Indication
Pneumococcal Infectious Disease
2 clinical trials
4 products
1 drug
Clinical trial
A Randomized, Double Blinded, Positive Controlled Phase Ⅰb Clinical Trial in Participants Aged 2 Months (42-89 Days) and 2 to 5 Years to Evaluate the Safety and Immunogenicity of 13-valent Pneumococcal Polysaccharide Conjugate VaccineStatus: Recruiting, Estimated PCD: 2024-09-02
Product
Prevnar 13Product
Sinovac PCV13Clinical trial
A Randomized, Double-blind, Controlled Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 24-valent Pneumococcal Conjugate Vaccine in Adults 18 Years of Age and OlderStatus: Not yet recruiting, Estimated PCD: 2024-12-20
Product
Sinovac PCV24Product
Pneumovax®Drug
Varlilumab